Big Data Clinical Research Development Engineer 
pharmaphorum
SEPTEMBER 16, 2022
With approximately one third of all current FDA-approved drugs targeting GPCRs, Verily/Sosei Heptares are looking to expedite GPCR research within not only immunology, but also gastroenterology and immuno-oncology as well, and the latest data bodes well for future development of therapeutic options in these areas.
Rethinking Clinical Trials
JUNE 26, 2023
Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD), shared his thoughts on national priorities for reducing health disparities and opportunities for clinical researchers to help promote health equity. He recommended sitting down with people as equals to co-develop research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2022
Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.
XTalks
MAY 9, 2024
As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.
Drug Discovery World
DECEMBER 20, 2022
The company also predicts a shift to democratised and digitised healthcare data, a prioritisation of real-world data, and recognition of the role of ‘clinical inertia’ in the uptake of new treatments. . AI will take on a wider role. M&A activity will accelerate.
pharmaphorum
MAY 25, 2021
A recent pharmaphorum webinar , held in partnership with Savana and BREATHE – the Health Data Research Hub for Respiratory Health, heard that RWE is also accelerating the development of new and innovative therapies and treatments to improve patient outcomes. The benefits of RWE.
The Pharma Data
JANUARY 12, 2021
Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations.
Expert insights. Personalized for you.
135 
Let's personalize your content